7 results
Table 4. Recommended Initial Empiric Antibiotic Therapy for Hospital-Acquired Pneumonia (Non-Ventilator-Associated Pneumonia) #Management #InfectiousDiseases #Empiric #Antibiotics
Antibiotic Therapy ... ) #Management #InfectiousDiseases ... #Empiric #Antibiotics ... #HAP #HCAP #HospitalAcquiredPneumonia ... #IDSA2016
Table 3. Suggested Empiric Treatment Options for Clinically Suspected Ventilator-Associated Pneumonia in Units Where Empiric Methicillin-Resistant
Ventilator-Associated Pneumonia ... Appropriate #Management #InfectiousDiseases ... #Empiric #Antibiotics ... #VAP #VentilatorAssociatedPneumonia ... #IDSA2016
IDSA Risk Factors for Multidrug-Resistant Pathogens 

#Diagnosis #Management #InfectiousDiseases #MDRO #RiskFactors #HAP #VAP #HCAP #IDSA2016 #Guidelines
Diagnosis #Management #InfectiousDiseases ... #RiskFactors #HAP ... #VAP #HCAP #IDSA2016 ... #Guidelines #Pneumonia
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Community-Acquired Pneumonia ... (CAP) No comorbidities ... IDSA #Outpatient #CAP ... #Antibiotics #Treatment ... Management #Guidelines #pharmacology
Community Acquired Pneumonia (CAP) - Diagnosis and Management

Pneumonia Signs/Symptoms:
 • Confusion/disorientation (LR + 1.9)
 • Cough
(CAP) - Diagnosis ... Obtain in severe CAP ... Pseudomonas) • Severe CAP ... radiographically confirmed CAP ... #CAP #Diagnosis
Anti-Pseudomonal - Antibiotics Class Overview

Pseudomonas aeruginosa is a non-fermenting Gram-negative bacillus that inhabits a variety of
Anti-Pseudomonal - Antibiotics ... nosocomial infections (HAP ... /VAP, catheter-related ... monotherapy for empiric ... Polymyxin B(IV) #Pharmacology
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
Azithromycin - Antibiotics ... community-acquired pneumonia ... Ceftriaxone for CAP ... #Pharmacology #Antibiotics